retatrutide nafld STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity Retatrutide Triple Agonist Research Peptide
Description
[1] Current NHS availability is limited
Like restrictive diets and intense exercise, GLP-1 treatments can lead to muscle mass loss unless used in combination with nutritional advice, such as specific daily protein targets
Additionally, a small retrospective series described 17 patients with perianal fistulizing CD treated with a GLP-1RA, reporting improvements in fistula drainage and pain scores
The Pound of Cure Platinum Program To help you get access to expert weight loss care, and GLP-1 medications in the most cost-efficient way possible, we created the Pound of Cure Platinum Program
Severe, persistent pain especially radiating to the back should always trigger medical evaluation rather than being attributed to routine GI side effects
